Summary
62 / 100 · Bulios Score
What speaks for it
- It has no debt and holds ฿1.06B in cash.
- The share price is below the Bulios Fair Price.
What to watch
- Earnings per share fell by 2.7% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against the industry (Medical - Care Facilities)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.4 THB for 1 THB of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (THB)
Diluted EPS (THB)
Revenue grew by 4.8% a year over 5 years. Over the last 3 years it grew by 1.7% a year. Earnings per share fell by 2.7% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 THB of revenue goes
- Cost of sales 75 THB
- Sales and administration 14 THB
- Taxes and other 1.1 THB
- Net profit 9.9 THB
Net profit, industry median (Medical - Care Facilities) 31 THB
Out of every 100 THB of revenue, 9.9 THB is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail